Related by context. All words. (Click for frequent words.) 71 sorafenib Nexavar 71 bevacizumab Avastin 70 HuMax EGFr 70 gemcitabine Gemzar 70 CoFactor 69 pertuzumab 68 ixabepilone 68 standard chemotherapy regimen 68 relapsed SCLC 68 trabectedin 68 mycophenolate mofetil 68 AZILECT ® 68 FASLODEX 67 riociguat 67 Amplimexon 67 tipranavir 67 teriflunomide 67 Ophena 67 XELOX 67 docetaxel Taxotere 67 OncoVEX GM CSF 67 Avastin bevacizumab 67 oral ridaforolimus 67 Targretin 67 bicalutamide 67 pegylated liposomal doxorubicin 67 Taxotere ® 67 Xanafide 67 Sanofi Aventis Taxotere 67 YONDELIS 67 Aplidin 67 Xelox 67 bevacizumab Avastin ® 67 MAGE A3 ASCI 66 ARIMIDEX 66 EFAPROXYN 66 tiotropium bromide 66 sargramostim 66 Ophena TM 66 enzastaurin 66 trastuzumab Herceptin 66 carboplatin paclitaxel 66 pharmacodynamic properties 66 Tarceva TM 66 Combo Stent 66 Doxil ® 66 DOXIL 66 KRAS status 66 temsirolimus 66 oral FTY# 66 FOLFOX6 66 cisplatin gemcitabine 66 Protelos 66 lapatinib Tykerb 66 colesevelam HCl 66 Irinotecan 66 evaluating tivozanib 66 protease inhibitor PI 66 Panzem R NCD 66 Herceptin trastuzumab 66 oral rivaroxaban 65 ProSavin 65 FOLFIRI 65 atrasentan 65 Traficet EN 65 ADAGIO study 65 Gemzar ® 65 goserelin 65 bendamustine 65 pegylated interferon alfa 65 peginterferon alfa 2b 65 cediranib 65 Trastuzumab 65 DAVANAT 65 HuLuc# 65 PRT# 65 NATRECOR ® 65 metastatic castration resistant 65 ZD# [001] 65 infusional 5-FU/LV 65 iniparib 65 romidepsin 65 Visipaque 65 tanespimycin 65 SIR Spheres 65 ELACYT 65 Tyrima 65 sunitinib malate 65 antitumor effect 65 interferon alfa 2b 65 Perforomist ™ Inhalation Solution 65 entinostat 65 chemoradiotherapy 65 azacitidine 65 docetaxel Taxotere ® 65 Pertuzumab 65 lenalidomide dexamethasone 65 neratinib 65 thalidomide Thalomid 65 Pazopanib 65 HuMax CD4 65 Pemetrexed 65 Mepact 65 paclitaxel Taxol ® 65 BENICAR HCT 64 regorafenib 64 calcineurin inhibitors 64 strontium ranelate 64 pegylated interferon alfa 2b 64 BRIM2 64 Xinlay 64 oxaliplatin Eloxatin 64 Bezielle 64 CIMZIA ™ 64 tocilizumab 64 eprotirome 64 erlotinib Tarceva ® 64 vidofludimus 64 viral kinetics 64 ACTEMRA TM 64 LT NS# 64 TYKERB 64 Cytoxan 64 mapatumumab 64 QuadraSphere 64 zalutumumab 64 boosted protease inhibitor 64 adecatumumab 64 Votrient 64 idraparinux 64 Torisel 64 angiotensin receptor blocker ARB 64 phase IIb trial 64 brivaracetam 64 radezolid 64 chemotherapeutic regimen 64 alvespimycin 64 recurrent GBM 64 anti angiogenic therapy 64 paclitaxel Taxol R 64 Onrigin 64 favorable pharmacokinetic profile 64 gemcitabine chemotherapy 64 CANCIDAS 64 eplerenone 64 candesartan cilexetil 64 docetaxel Taxotere R 64 Quinamed 64 EOquin 64 delafloxacin 64 paclitaxel Taxol 64 ARIKACE 64 ToGA 64 decitabine 64 EOquin TM 64 MGd 64 alpha 2a 64 PROCHYMAL 64 Azedra 64 INCB# [001] 64 5 FU leucovorin 64 ZOLINZA 64 cetuximab Erbitux ® 64 HyQ 64 Combination therapy 64 ARIXTRA 64 TEMODAL 64 5-FU/LV 64 AVASTIN 64 adjuvant radiotherapy 64 Removab 64 pan HDAC inhibitor 63 Taxol ® 63 posaconazole 63 Angiolix 63 Vitaxin 63 TriRima 63 BRAF inhibitor 63 HGS# 63 phase IIa clinical 63 reslizumab 63 olaparib 63 pegylated interferons 63 pomalidomide 63 antiangiogenic therapy 63 MERLIN TIMI 63 Revlimid lenalidomide 63 mRCC 63 Aflibercept 63 adjuvant radiation 63 Dabigatran etexilate 63 FOLFOX4 63 APTIVUS 63 cetuximab Erbitux 63 tesmilifene 63 ganetespib 63 vorinostat 63 nitazoxanide 63 Vandetanib 63 Erlotinib 63 exemestane Aromasin 63 relapsed MM 63 nab paclitaxel 63 LEUKINE 63 Proxinium TM 63 ILLUMINATE 63 forodesine 63 MYDICAR ® 63 docetaxel chemotherapy 63 letrozole Femara 63 rosuvastatin #mg 63 ovarian suppression 63 pioglitazone Actos 63 SABCS 63 Taxol paclitaxel 63 DU #b 63 CBLC# 63 canakinumab 63 zoledronic acid Zometa 63 bevacizumab Avastin Genentech 63 Paraplatin ® 63 elacytarabine 63 Onbrez Breezhaler 63 Mylotarg 63 bortezomib Velcade 63 axitinib 63 Alocrest 63 Mycamine 63 Vectibix monotherapy 63 ELOXATIN 63 Ceflatonin 63 nilotinib 63 tinidazole 63 phase Ib 63 biologic DMARD 63 lumiliximab 63 SCIg 63 AEG# 63 indacaterol 63 Taxotere chemotherapy 63 ATACAND 63 farletuzumab 63 capecitabine Xeloda 63 erlotinib Tarceva 63 TG# [003] 63 trastuzumab Herceptin R 63 PRADAXA 63 Nexavar sorafenib 63 nesiritide 63 Exforge HCT 63 Dual Opioid 63 Factor Xa inhibitor 63 metastatic RCC 63 velafermin 63 Phase Ib II 62 NCCN guidelines 62 GP IIb IIIa inhibitors 62 Vidaza azacitidine 62 ABVD 62 Xeloda capecitabine 62 clinically meaningful efficacy 62 Faslodex 62 ularitide 62 relapsed multiple myeloma 62 Pfizer Sutent 62 ibandronate 62 INC# 62 dacarbazine 62 BeneFIX 62 Fludara 62 sorafenib tablets 62 tolvaptan 62 oral anticoagulation 62 IRESSA 62 neoadjuvant chemotherapy 62 Hycamtin ® 62 Tarceva erlotinib 62 heavily pretreated patients 62 Abatacept 62 CaPre TM 62 proteasome inhibitor bortezomib 62 Phase Ib study 62 Lenalidomide 62 complete cytogenetic response 62 abatacept Orencia 62 vascular disrupting agents 62 Ranolazine 62 pain palliation 62 chemotherapy FOLFOX 62 concurrent chemoradiation 62 LCP Tacro ™ 62 Amrubicin 62 elotuzumab 62 Copegus ribavirin 62 amifostine 62 metastatic hormone refractory 62 Xeloda ® 62 HuMax CD# 62 OXi# 62 adriamycin 62 pazopanib 62 PROSTVAC TM 62 neoadjuvant treatment 62 Campath alemtuzumab 62 invasive candidiasis 62 VAPRISOL 62 Leukine ® 62 fluvastatin 62 lenalidomide Revlimid R 62 pemetrexed Alimta 62 Arixtra ® 62 obatoclax 62 sevelamer 62 Tarvacin 62 angiotensin II receptor blocker 62 Platinol ® 62 postoperative chemotherapy 62 PSMA ADC 62 rNAPc2 62 chemotherapeutic drug 62 NeoRecormon 62 lintuzumab 62 CR# vcMMAE 62 ticagrelor Brilinta 62 Allovectin 7 62 anti EGFR antibody 62 Omnitarg 62 ritonavir boosted 62 NEVO ™ 62 chemoembolization 62 HER2 positive metastatic breast 62 phase IIIb 62 TORISEL 62 oral prodrug 62 ZYVOX 62 darunavir ritonavir 62 pegfilgrastim 62 FOLFOX6 chemotherapy regimen 62 glatiramer acetate 62 TLK# 62 preclinically 62 XmAb# 62 rALLy trial 62 Sandostatin LAR 62 Oxaliplatin 62 paclitaxel poliglumex 62 tenofovir emtricitabine 62 Diovan HCT 62 AEGR 62 antioxidant supplementation 62 gefitinib Iressa 62 antiplatelet agent 62 AVADO 62 Bevacizumab 62 fluoropyrimidine 62 KRN# 62 pimecrolimus 62 Carfilzomib 62 Cloretazine 62 tigecycline 62 Doxil 62 IMA# 62 low dose cytarabine 62 FUSILEV enhances 62 Chemophase 62 Roche Xeloda 62 amrubicin 62 Apoptone 62 Gemcitabine 62 AZILECT 62 talabostat 62 irinotecan chemotherapy 62 CYT# potent vascular disrupting 62 dabigatran etexilate 62 cinacalcet 62 liposomal formulation 62 idarubicin 62 HGS ETR2 62 NXL# 62 RoACTEMRA 62 nucleotide analogue 62 APOPTONE 62 APTIVUS R 62 efalizumab 62 MabCampath 62 sunitinib Sutent 62 gemcitabine cisplatin 62 DAPT 62 gemcitabine carboplatin 62 QVAR ® 62 antiangiogenic agent 62 Camptosar ® 62 PEG interferon 62 intensive lipid lowering 62 Rituxan rituximab 62 MYCAMINE 62 antithrombotic 62 galiximab 62 anastrozole 62 indibulin 62 lixisenatide 62 AZILECT R 62 ximelagatran 62 Oncotype DX Recurrence Score 62 Gefitinib 62 stavudine d4T 61 Dabigatran 61 mTOR inhibitor 61 overlapping toxicities 61 Fulvestrant 61 Vivaglobin 61 Cetuximab Erbitux 61 Capesaris 61 Taxotere R 61 abciximab 61 irbesartan 61 ZYBRESTAT 61 TAXOTERE R 61 pramlintide metreleptin combination 61 fenofibric acid 61 Evoltra 61 PTNS 61 refractory AML 61 Pegasys peginterferon alfa 2a 61 GRASPA ® 61 CHOP chemotherapy 61 DFMO 61 receptor tyrosine kinase inhibitor 61 INT# [002] 61 pralatrexate 61 doxorubicin HCl liposome injection 61 basal bolus regimen 61 anidulafungin 61 neoadjuvant 61 TroVax ® 61 AVANDIA 61 IRX 2 61 Hycamtin 61 rosuvastatin Crestor 61 metastatic renal cell carcinoma 61 raloxifene Evista 61 zoledronic acid 61 metaglidasen 61 vildagliptin 61 BRIM3 61 Femara letrozole 61 DDP# 61 PROMACTA 61 INTELENCE 61 etanercept Enbrel 61 Reverset 61 Myocet 61 ThermoDox ® 61 standard chemotherapy regimens 61 Cimzia R 61 angiogenesis inhibitor 61 AVOREN 61 Zemplar Capsules 61 NVA# 61 dacetuzumab 61 Aclasta 61 RE LY 61 ezetimibe simvastatin 61 Rebif ® 61 abacavir lamivudine 61 Degarelix 61 trastuzumab emtansine T DM1 61 liposomal doxorubicin 61 pemetrexed 61 Everolimus 61 GFT# 61 nebulized formoterol fumarate 61 ACAPODENE 61 imexon 61 atacicept 61 aspirin clopidogrel 61 Virulizin ® 61 enoximone 61 RLY# 61 Prostate AdenoCarcinoma Treatment 61 plus dexamethasone 61 peginterferon alfa 2a Pegasys 61 apremilast 61 TroVax 61 Allovectin 7 ® 61 FOLFIRINOX 61 dasatinib 61 zanolimumab 61 crizotinib PF # 61 PXD# 61 fluticasone salmeterol 61 cabazitaxel 61 valsartan Diovan 61 plasma kallikrein inhibitor 61 aldosterone antagonists 61 Dasatinib 61 pitavastatin 61 Leukine 61 virus HCV protease inhibitor 61 atorvastatin Lipitor 61 Zarnestra 61 taxane therapy 61 Halaven 61 Moxifloxacin 61 Tekturna HCT 61 CINQUIL 61 ULORIC 61 CA4P 61 SPIRIT IV 61 thymalfasin 61 FOLPI 61 biologic therapy 61 ThermoDox R 61 Catena ® 61 intravenous bisphosphonates 61 evaluating REVLIMID 61 subgroup analyzes 61 nucleoside analog 61 SNT MC# 61 relapsed ovarian cancer 61 COPEGUS 61 sipuleucel T 61 aleglitazar 61 ACZ# 61 KRAS mutation 61 chemopreventive agent 61 Kepivance 61 pharmacokinetic PK study 61 pediatric acute lymphoblastic 61 IMP# 61 refractory chronic lymphocytic 61 desvenlafaxine 61 Fludara ® 61 Phase 2a trial 61 Octreolin 61 fluorouracil 61 mCRC patients 61 HGS ETR1 61 Jevtana 61 mertansine 61 clodronate 61 bortezomib Velcade ® 61 chemotherapy cisplatin 61 BAL# [002] 61 tiotropium 61 bexarotene 61 menadione 61 CIMZIA TM 61 Neulasta ® 61 adefovir dipivoxil 61 convenient dosing regimens 61 CAELYX 61 Mipomersen 61 oral chemotherapeutic agent 61 Tiotropium 61 methylnaltrexone 61 Telmisartan 61 glargine 61 Natalizumab 61 Neoadjuvant 61 Epratuzumab 61 AZT zidovudine Retrovir 61 Dapagliflozin 61 radiochemotherapy 61 Nexavar ® 61 SIMCOR 61 lasofoxifene 61 pegylated interferon alpha 2a 61 bortezomib 61 radiation sensitizer 61 alfa 2a 61 favorable tolerability 61 cangrelor 61 deforolimus 61 sorafenib Nexavar ® 61 RhuDex ® 61 resminostat 60 Afatinib 60 oral antiplatelet 60 Vectibix panitumumab 60 BAY #-# 60 WelChol 60 PRECISE 60 Peginterferon 60 hormone refractory metastatic prostate 60 TTF Therapy 60 Privigen 60 EDARBI 60 ADVANCE PD 60 cytotoxic therapy 60 CTAP# Capsules 60 Valdoxan 60 Golimumab 60 miconazole 60 zidovudine AZT 60 deferiprone 60 Nebido 60 Insegia 60 Aliskiren 60 antithrombotics 60 CYPHER R Sirolimus eluting 60 somatostatin analogues 60 biologic plausibility 60 5 Fluorouracil 60 CYPHER Stent 60 tiuxetan 60 ONTARGET 60 locoregional recurrence 60 COPAXONE R 60 conventional coronary angiography 60 imatinib Gleevec ® 60 phase 2a 60 Advagraf 60 Betaferon ® 60 TRILIPIX 60 Clolar ® 60 salmeterol fluticasone 60 muraglitazar 60 Capecitabine 60 VNP#M 60 noninferiority 60 ISTODAX 60 oral anticoagulant 60 interferon alfa 60 tamoxifen Nolvadex ® 60 bevacizumab 60 Teriflunomide 60 olmesartan 60 alefacept 60 neoadjuvant therapy 60 JAK inhibitor 60 LY# [003] 60 OHR/AVR# 60 DACH platinum 60 VELCADE melphalan 60 atazanavir Reyataz 60 Phase 1b trial 60 YONDELIS R 60 imipenem 60 Velcade bortezomib 60 febuxostat 60 Zemplar 60 Spiriva Handihaler 60 SERMs 60 briakinumab 60 amprenavir 60 FOLFOX 60 GW# [003] 60 Peg IFN 60 tenofovir Viread 60 antitumor activity 60 G#DT 60 picoplatin 60 Cremophor 60 leucovorin 60 chromium supplementation 60 ENMD # 60 ASA# 60 GELNIQUE 60 OPAXIO 60 entecavir 60 Glufosfamide 60 BCIRG 60 Pegasys plus Copegus 60 Durezol 60 miconazole Lauriad ® 60 flavopiridol 60 Gleevec imatinib 60 active comparator 60 Telintra 60 pharmacologically active isomer 60 abiraterone acetate 60 insulin glargine 60 fosamprenavir 60 anti arrhythmic drug 60 fondaparinux 60 tyrosine kinase inhibitor 60 prasugrel Effient 60 Teysuno 60 EndoTAGTM 1 60 GAMMAGARD 60 Taxotere docetaxel 60 SUTENT 60 teriparatide 60 tenofovir DF 60 platelet inhibitor 60 CLORETAZINE TM VNP#M 60 Epirubicin 60 pioglitazone HCl 60 icatibant 60 temsirolimus Torisel ® 60 ranibizumab Lucentis 60 Losartan 60 Ceplene/IL-2 60 COMFORT II 60 PANVAC VF 60 gemcitabine Gemzar ® 60 samalizumab 60 Pharmacokinetic studies 60 Platinol ® cisplatin 60 alvimopan 60 Tavocept 60 CombAT 60 rasagiline tablets 60 cetuximab Erbitux R 60 solithromycin 60 ZACTIMA 60 HORIZONS AMI trial 60 Cotavance 60 VIRAMUNE 60 peginterferon alfa 2a 60 Rasilez Tekturna 60 Caelyx 60 Zolinza 60 Multaq R 60 vinca alkaloid 60 panitumumab Vectibix 60 ara C 60 Plicera 60 SCCHN 60 enfuvirtide 60 mitomycin 60 Xcytrin 60 preoperative chemotherapy 60 epirubicin 60 ARCOXIA 60 Navelbine ® 60 custirsen 60 estramustine 60 Actimmune ® 60 mTOR inhibitors 60 Panzem R 60 PKC# 60 gastrointestinal stromal tumors GIST 60 EGFR TKI 60 recurrent glioblastoma multiforme 60 uric acid lowering 60 GAP #B# 60 PegIntron 60 Panzem 60 SCH # 60 zoledronate 60 anti thrombotic 60 Bortezomib 60 mg kg BID 60 eltrombopag 60 systemic bioavailability 60 MIRCERA 60 cilostazol 60 alkylating agent 60 selenium supplementation 60 nevirapine Viramune 60 relapsed myeloma 60 Cetuximab 60 adjuvant therapy 60 oral antiviral 60 Guanilib 60 COPAXONE ® 60 phase IIb 60 S/GSK# 60 liposomal amphotericin B 60 elagolix 60 palifosfamide 60 UPLYSO 60 Elitek 60 iclaprim 60 antidiabetic drug 60 PEGASYS ® 60 pharmacokinetic PK 60 Arikace 60 Erbitux cetuximab 60 cardiovascular morbidity 60 placebo controlled clinical 60 low dose dexamethasone 60 Muraglitazar 60 Atacand 60 dasatinib Sprycel 60 Tanespimycin 60 Welchol 60 NEVO TM 60 REYATAZ R 60 GnRH agonists 60 HQK 60 vandetanib 60 inhaled corticosteroid ICS 60 TOCOSOL Paclitaxel 60 octreotide acetate 60 efficacy endpoint 60 orally dosed 60 TYGACIL 60 randomized Phase IIb 60 INTEGRILIN 60 fosbretabulin 60 alteplase 60 Interferon beta 60 anticancer activity 60 Rasilamlo 60 Bicalutamide 60 Peginterferon alfa 2b 60 therapeutic regimens 60 telaprevir dosed 60 APTIVUS r 60 liver metastasis 60 HERCEPTIN 59 Vidofludimus 59 dacarbazine DTIC 59 EndoTAG TM -1 59 Pegasys ® 59 risedronate 59 Treanda 59 virologic response 59 proton pump inhibitor PPI 59 lenalidomide Revlimid ® 59 Cimzia TM 59 fulvestrant 59 FIRMAGON 59 bortezomib Velcade R 59 imetelstat 59 micafungin 59 xanthine oxidase inhibitor 59 LEXIVA r 59 RAPAFLO R 59 baminercept 59 gadobutrol 59 BCX# 59 androgen independent 59 follicular NHL 59 PREZISTA r 59 MGCD# [001] 59 PD LID 59 afatinib 59 ketorolac 59 5FU 59 temozolomide TMZ 59 vinorelbine 59 multicentre randomized 59 docetaxel 59 RE LY trial 59 GRN#L 59 Silodosin 59 SUTENT ® 59 ongoing Phase 1b 59 #I TM# 59 anti leukemic 59 ALGRX 59 Boceprevir 59 Valsartan 59 Intervention Effectiveness 59 imiquimod cream 59 XYOTAX TM 59 LDL lowering 59 Lantus ® 59 abatacept 59 chlorambucil 59 certolizumab 59 casopitant 59 oral diclofenac 59 busulfan 59 Zoledronic acid 59 Temsirolimus 59 EGFR inhibitors 59 Carboplatin 59 Seliciclib 59 EUS FNA 59 Elotuzumab 59 LHRH agonists 59 adipiplon 59 bevacizumab Avastin R 59 depsipeptide 59 #D#C# 59 gefitinib 59 antiviral efficacy 59 Keppra XR 59 PDX pralatrexate 59 low dose ritonavir 59 ZK EPO 59 antiplatelet 59 randomized Phase III 59 Inhalation Solution 59 degarelix 59 Celgene Revlimid 59 fallopian tube carcinoma 59 endocrine therapy 59 rilonacept 59 CERVARIX 59 varespladib 59 metastatic CRC 59 PROCRIT ® 59 Tekturna aliskiren 59 Azilect ® 59 Intravenous CP 59 NP2 Enkephalin 59 recurrent glioblastoma 59 oxymorphone ER 59 talactoferrin 59 Aptivus 59 hereditary deficiency 59 trastuzumab Herceptin ® 59 cilengitide 59 Cotara 59 Aptivus ® 59 Stedivaze 59 ALA PDT 59 NO# [002] 59 chemotherapy gemcitabine 59 pCR 59 targeting CD# 59 Mycophenolate Mofetil 59 huC# DM4 59 Oral NKTR 59 virologic 59 Keppra R 59 FDG PET 59 LibiGel ® 59 anti androgen 59 Aclidinium 59 imatinib Gleevec 59 DMARD 59 paclitaxel carboplatin 59 KRAS mutations occur 59 Sorafenib Nexavar 59 Bivalirudin 59 bardoxolone methyl 59 raltegravir 59 antiplatelet drugs 59 randomized multicenter trial 59 everolimus eluting stents 59 Folfox 59 Betaferon R 59 HIF PH inhibitors 59 cidofovir 59 calcineurin inhibitor 59 Randomized clinical trials 59 QVA# 59 MabThera rituximab 59 sustained virological response 59 rituximab Rituxan 59 Phase Ib clinical 59 ADHF 59 cyclophosphamide Cytoxan 59 NEUGENE 59 VIDAZA 59 OvaRex ® MAb 59 Abiraterone acetate 59 seliciclib 59 VALSTAR 59 INCB# [003] 59 Solorel TM 59 PEGylated anti 59 Vernakalant 59 salmeterol inhalation powder 59 Targretin capsules 59 capecitabine Xeloda R 59 Telzir 59 aromatase inhibitors AIs 59 BrachySil TM 59 veltuzumab 59 PROLARIS 59 TAXUS Stent 59 anticancer agent 59 Mitoxantrone 59 potent CYP#A# inhibitors 59 Azacitidine 59 cobiprostone 59 ExTRACT TIMI 59 phase IIb study 59 BOLDER II 59 PHX# 59 glatiramer 59 Aromasin 59 BENICAR 59 SPIRIT FIRST 59 Phase #/#a trial 59 VFEND 59 APPRAISE 59 Zybrestat 59 antiplatelet therapies 59 efficacy tolerability 59 pegylated interferon alfa 2a 59 Exemestane 59 pamidronate 59 agomelatine 59 ONGLYZA 59 aflibercept 59 Tezampanel 59 aripiprazole Abilify 59 PIX# [002] 59 SPIRIVA HandiHaler 59 intravenous dosing 59 ACCORD Lipid 59 chemoradiation 59 mcg dose 59 ruboxistaurin 59 edoxaban 59 LYSTEDA 59 EGS# 59 GVAX 59 adalimumab 59 STRIDE PD